ArticleThe pharmacogenomics journal2025

Impact of low BMI and ABCC2 genotype on the clinical response of sequential anthracycline-taxane chemotherapy receiving breast cancer patients: a hospital-based study.

Tanuma Mistry et al.PubMed ↗Publisher ↗

No numbers read from the abstract.